OCGN FY 2016 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$710M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$30M

Net Income

-$16M

EPS (Diluted)

$-67.58

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$36M

Total Liabilities

$23M

Stockholders' Equity

$14M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	-$2M	-3.7%
Operating Income	-$30M	-$32M	+4.8%
Net Income	-$16M	-$32M	+49.4%